Small-molecule CRTH2 antagonists for the treatment of allergic inflammation: an overview

By Ly Tai Wei   Bacon Kevin B  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 7, 2005-07 ,pp. : 769-773

Informa Healthcare

Access to resources Recommend Favorite

Characterization of chimeric prostacyclin/prostaglandin D 2 receptors

By Wise H.  

European Journal of Pharmacology, Vol. 386, Iss. 1, 1999-12 ,pp. : 89-96

Elsevier

Access to resources Recommend Favorite

Targeting inflammation: multiple innovative ways to reduce prostaglandin E 2

By Norberg Jessica K   Sells Earlphia   Chang Hui-Hua   Alla Srinivas R   Zhang Shuxing   Meuillet Emmanuelle J  

Pharmaceutical Patent Analyst, Vol. 2, Iss. 2, 2013-03 ,pp. : 265-288

Future Science

Access to resources Recommend Favorite

A novel biological role for prostaglandin D 2 is suggested by distribution studies of the rat DP prostanoid receptor

By Wright D.H.   Nantel F.   Metters K.M.   Ford-Hutchinson A.W.  

European Journal of Pharmacology, Vol. 377, Iss. 1, 1999-07 ,pp. : 101-115

Elsevier

Access to resources Recommend Favorite

Therapeutic Targeting of Type 2 Inflammation for the Treatment of Severe Asthma

By  

Clinical Anti-Inflammatory & Anti-Allergy Drugs, Vol. 1, Iss. 1, 2014-04 ,pp. : 2-10

Bentham Science Publishers

Access to resources Recommend Favorite